GPP
Great Point Partners’s Larimar Therapeutics LRMR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-900,000
| Closed | -$4.08M | – | 43 |
|
|
2023
Q1 | $4.08M | Sell |
900,000
-373,635
| -29% | -$1.69M | 0.8% | 32 |
|
|
2022
Q4 | $5.26M | Buy |
1,273,635
+138,635
| +12% | +$573K | 1.03% | 32 |
|
|
2022
Q3 | $3.63M | Buy |
+1,135,000
| New | +$3.63M | 0.87% | 30 |
|
|
2019
Q3 | – | Sell |
-2,211,194
| Closed | -$2.63M | – | 36 |
|
|
2019
Q2 | $2.63M | Sell |
2,211,194
-899,680
| -29% | -$1.07M | 0.29% | 24 |
|
|
2019
Q1 | $8.52M | Sell |
3,110,874
-487,518
| -14% | -$1.34M | 0.84% | 24 |
|
|
2018
Q4 | $17.8M | Buy |
3,598,392
+207,007
| +6% | +$1.02M | 2.25% | 16 |
|
|
2018
Q3 | $39.6M | Sell |
3,391,385
-108,615
| -3% | -$1.27M | 6.18% | 3 |
|
|
2018
Q2 | $35.8M | Buy |
+3,500,000
| New | +$35.8M | 4.96% | 7 |
|
|
2014
Q4 | – | Sell |
-16,855
| Closed | -$331K | – | 31 |
|
|
2014
Q3 | $331K | Buy |
+16,855
| New | +$331K | 0.14% | 34 |
|